Kythera Biopharmaceuticals Inc news

   Watch this stock
Showing stories 1 - 10 of about 93   

Articles published

KYTH 74.70 +0.01 (0.01%)
price chart
Shares of Kythera Biopharmaceuticals, Inc. (NASDAQ:KYTH) Sees Large Inflow of ...
Kythera Biopharmaceuticals, Inc. (NASDAQ:KYTH) witnessed a selling pressure and the shares last traded with a loss of -0.01 points or -0.01% at $74.71.
Kythera Biopharmaceuticals, Inc. (NASDAQ:KYTH) Price Target Update  Insider Trading Report
Stock Insights: Kythera Biopharmaceuticals, Inc. (NASDAQ:KYTH)  Vanguard Tribune
Allergan to Buy Kythera Biopharmaceuticals for $2.1 Billion
Allergan Plc, the maker of wrinkle treatment Botox, agreed to buy Kythera Biopharmaceuticals Inc. for about $2.1 billion to add treatments for double chins and male pattern baldness.
Why Kythera Biopharmaceuticals, Inc. Stock Soared Today  Motley Fool
Why Kythera Biopharmaceuticals, Inc Rocketed Higher
What's happening: Shares of Kythera Biopharmaceuticals (NASDAQ:KYTH) soared higher by as much as 20% ahead of a key FDA advisory panel committee meeting next week.
FDA staff backs injection to reduce double chin  Reuters
Shares of Kythera Biopharmaceuticals, Inc. (NASDAQ:KYTH) Rally 0.11%
Shares of Kythera Biopharmaceuticals, Inc. (NASDAQ:KYTH) rose by 0.11% in the past week and 0.7% for the last 4 weeks.
Stock's Trend Analysis Report - Franklin Resources, Inc. (NYSE:BEN ...  wsnewspublishers
Kythera Biopharmaceuticals Inc. (NASDAQ:KYTH) is going to be acquired by ...
Kythera Biopharmaceuticals Inc. (NASDAQ:KYTH) opened trading today as $74.21 and is trading in the range of 74.03-74.39 today.
Morgan & Morgan Announces the Investigation of KYTHERA ...  PR Newswire (press release)
KYTHERA BIOPHARMACEUTICALS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P ...  Business Wire (press release)
Why Keith Leonard Unloaded 3500 Shares of Kythera Biopharmaceuticals Inc ...
In view of the deal Keith Leonard made he is in the bear's eye today. The President & CEO of Kythera Biopharmaceuticals Inc (NASDAQ:KYTH) 74.70 +0.01 0.01% and an insider, made a sale of 3,500 shares worth $175,151 USD. The average price was ...
Kythera Biopharmaceuticals, Inc. (NASDAQ:KYTH) Given $64-$75 PT Range
According to the analysts polled by Zack's Research, Kythera Biopharmaceuticals, Inc. (NASDAQ:KYTH) has been given a one year consensus price target range of $64 to $75.
Kythera Biopharmaceuticals, Inc. Short Interest Update  American Trade Journal
Shares of Kythera Biopharmaceuticals, Inc. (NASDAQ:KYTH) Sees Large Outflow ...  News Watch International
Sell Kythera (KYTH) Stock, Another Biotech Ripoff
Kythera Biopharmaceuticals Inc (NASDAQ:KYTH) stock was halted Monday as an independent advisory committee reviewed its double-chin treatment, ATX-101.
Kythera Biopharmaceuticals Inc's (KYTH) Double-Chin Treatment Backed By ...  Bidness ETC
KYTHERA Biopharmaceuticals Announces Pricing of Public Offering of Common Stock  GlobeNewswire (press release)
Why Allergan Plc Just Disclosed Huge New Kythera Biopharmaceuticals Inc Stake
Allergan Plc has filled a SC 13D form regarding Kythera Biopharmaceuticals Inc 74.70 +0.01 0.01% . Filing Link: 000119312515239534.
Leerink Downgrades Kythera, Says Allergan Deal Likely To Close At $75 Mark  Benzinga
Leerink Swann Downgrades Kythera Biopharmaceuticals to Market Perform (KYTH)  WKRB News
Kythera Biopharmaceuticals, Inc. Price Target Update
Kythera Biopharmaceuticals, Inc. (NASDAQ:KYTH) shares are expected to touch $68.33 in the short term. This short term price target has been shared by 3 analysts.